2 Potential Biotech Doublers
Today’s article features two biotech stocks that analysts believe have the potential to double over the next 12 months. The first company is developing therapies… Read More »2 Potential Biotech Doublers
Stock Market
How To Choose Which Biotech Stocks To Pull The Trigger On
“Remember, no other sector sees stocks move 50% or even more than 100% in a day on a takeover announcement,” notes the author of today’s… Read More »How To Choose Which Biotech Stocks To Pull The Trigger On
Looking For Wins In The Biotech Space
As biotech stocks experience a broad correction, the analyst cited in today’s article sees “a number of compelling values” in the space. In particular, he… Read More »Looking For Wins In The Biotech Space
“Powered By The Pandemic”: An Attractive Entry Point For This Small-Cap Biotech?
The small-cap biotech featured in today’s article develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries. As… Read More »“Powered By The Pandemic”: An Attractive Entry Point For This Small-Cap Biotech?
Catalysts & Analysts: Why These 2 Biotech Stocks Have Impressive Upside Potential
When it comes to the best way to gauge biotech stocks ahead of big catalysts, the author of today’s article recommends turning to Wall Street… Read More »Catalysts & Analysts: Why These 2 Biotech Stocks Have Impressive Upside Potential
These 3 Struggling Biotechs Could Experience Spring Bumps
When it comes to the three biotech stocks featured in today’s article, all of which have experienced recent struggles, the author notes that their management… Read More »These 3 Struggling Biotechs Could Experience Spring Bumps
Is This COVID-19 Test Manufacturer’s Spectacular Growth Story Nearing Its End – Or Entering The Next Chapter?
As a manufacturer of COVID-19 tests – and the top provider of COVID-19 testing in California – the company featured in today’s article has seen… Read More »Is This COVID-19 Test Manufacturer’s Spectacular Growth Story Nearing Its End – Or Entering The Next Chapter?
Contraindicated: Why These 3 Biotech Stocks With Massive Gains Could Be Toxic For Portfolios
With a potential treatment for Alzheimer’s disease, a deal to co-develop a proven-effective COVID-19 vaccine for the U.S. market, and a platform of red-blood-cell-based cancer… Read More »Contraindicated: Why These 3 Biotech Stocks With Massive Gains Could Be Toxic For Portfolios
With Their Pipelines And Upcoming Catalysts, These 3 Biotech Stocks Have The Potential To More Than Double
When it comes to biotech stocks, the author of today’s article notes that “An investment decision backed by careful scrutiny and analysis — of a company’s pipeline,… Read More »With Their Pipelines And Upcoming Catalysts, These 3 Biotech Stocks Have The Potential To More Than Double
An Easy Way For Anyone To Find Compelling Biotech Stocks
Unless you’re a full-time trader who’s able to spend all day researching and developing stock screens, it’s not easy to find compelling biotech stocks, right?… Read More »An Easy Way For Anyone To Find Compelling Biotech Stocks